Notably, IDO inhibitors, such as 1‐methyltryptophan and epigallocatechin gallate, have demonstrated efficacy in preventing the formation of colonic preneoplastic lesions, representing a novel strategy for colon cancer prevention [87]. This evidence concerns the gene IDO1 and colonic neoplasm.